Patterns of cervical coinfection with multiple human papilloma virus types in a screening population in Denmark

Vaccine

Volumn 31, Issue 12, 2013, Pages 1604-1609

  Goldman, Bryan ^a   Rebolj, Matejka ^a   Rygaard, Carsten ^b   Preisler, Sarah ^b   Ejegod, Ditte Møller ^b   Lynge, Elsebeth ^a   Bonde, Jesper ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Cervical cancer; Coinfection; Denmark; HPV vaccination; Human papillomavirus

Indexed keywords

ADULT; ARTICLE; BOVINE PAPILLOMAVIRUS TYPE 3; CONTROLLED STUDY; DENMARK; FEMALE; GENETIC HETEROGENEITY; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 6; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; MIXED INFECTION; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SIMULATION; STATISTICAL SIGNIFICANCE; UTERINE CERVIX CANCER; WART VIRUS;

ADULT; AGED; CERVIX UTERI; COINFECTION; COMPUTER SIMULATION; DENMARK; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PREVALENCE; RISK FACTORS; YOUNG ADULT;

EID: 84875265658     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.12.084     Document Type: Article

References (32)

1. Bosch F.X., Lorincz A., Munoz N., Meijer C.J., Shah K.V. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002, 55(April (4)):244-265.
2. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999, 189(September (1)):12-19.
3. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002, 2(May (5)):342-350.
4. de Sanjose S., Quint W.G., Alemany L., Geraets D.T., Klaustermeier J.E., Lloveras B., et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 2010, 11(November (11)):1048-1056.
5. De Vuyst H., Clifford G., Li N., Franceschi S. HPV infection in Europe. Eur J Cancer 2009, 45(October (15)):2632-2639.
6. Merck Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001 AM2). URL: [last accessed: 23.08.12]. http://clinicaltrials.gov/ct2/show/NCT00543543.
7. Bello B.D., Spinillo A., Alberizzi P., Cesari S., Gardella B., D'Ambrosio G., et al. Cervical infections by multiple human papillomavirus (HPV) genotypes: prevalence and impact on the risk of precancerous epithelial lesions. J Med Virol 2009, 81(April (4)):703-712.
8. Carozzi F., Ronco G., Gillio-Tos A., De Marco L., Del Mistro A., Girlando S., et al. Concurrent infections with multiple human papillomavirus (HPV) types in the New Technologies for Cervical Cancer (NTCC) screening study. Eur J Cancer 2012, 48(July (11)):1633-1637.
9. Chaturvedi A.K., Katki H.A., Hildesheim A., Rodriguez A.C., Quint W., Schiffman M., et al. Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical disease. J Infect Dis 2011, 203(April (7)):910-920.
10. Cuschieri K.S., Cubie H.A., Whitley M.W., Seagar A.L., Arends M.J., Moore C., et al. Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population. J Clin Pathol 2004, 57(January (1)):68-72.
11. Mejlhede N., Bonde J., Fomsgaard A. High frequency of multiple HPV types in cervical specimens from Danish women. APMIS 2009, 117(February (2)):108-114.
12. Mejlhede N., Pedersen B.V., Frisch M., Fomsgaard A. Multiple human papilloma virus types in cervical infections: competition or synergy?. APMIS 2010, 118(May (5)):346-352.
13. Mendez F., Munoz N., Posso H., Molano M., Moreno V., van den Brule A.J., et al. Cervical coinfection with human papillomavirus (HPV) types and possible implications for the prevention of cervical cancer by HPV vaccines. J Infect Dis 2005, 192(October (7)):1158-1165.
14. Rousseau M.C., Abrahamowicz M., Villa L.L., Costa M.C., Rohan T.E., Franco E.L. Predictors of cervical coinfection with multiple human papillomavirus types. Cancer Epidemiol Biomarkers Prev 2003, 12(October (10)):1029-1037.
15. Spinillo A., Dal Bello B., Alberizzi P., Cesari S., Gardella B., Roccio M., et al. Clustering patterns of human papillomavirus genotypes in multiple infections. Virus Res 2009, 142(June (1-2)):154-159.
16. Thomas K.K., Hughes J.P., Kuypers J.M., Kiviat N.B., Lee S.K., Adam D.E., et al. Concurrent and sequential acquisition of different genital human papillomavirus types. J Infect Dis 2000, 182(October (4)):1097-1102.
17. Trottier H., Mahmud S., Costa M.C., Sobrinho J.P., Duarte-Franco E., Rohan T.E., et al. Human papillomavirus infections with multiple types and risk of cervical neoplasia. Cancer Epidemiol Biomarkers Prev 2006, 15(July (7)):1274-1280.
18. Vaccarella S., Franceschi S., Snijders P.J., Herrero R., Meijer C.J., Plummer M. Concurrent infection with multiple human papillomavirus types: pooled analysis of the IARC HPV Prevalence Surveys. Cancer Epidemiol Biomarkers Prev 2010, 19(February (2)):503-510.
19. Vaccarella S., Franceschi S., Herrero R., Schiffman M., Rodriguez A.C., Hildesheim A., et al. Clustering of multiple human papillomavirus infections in women from a population-based study in Guanacaste, Costa Rica. J Infect Dis 2011, 204(August (3)):385-390.
20. Wheeler C.M., Hunt W.C., Schiffman M., Castle P.E. Human papillomavirus genotypes and the cumulative 2-year risk of cervical precancer. J Infect Dis 2006, 194(November (9)):1291-1299.
21. Plummer M., Vaccarella S., Franceschi S. Multiple human papillomavirus infections: the exception or the rule?. J Infect Dis 2011, 203(April (7)):891-893.
22. Kjaer S.K., Breugelmans G., Munk C., Junge J., Watson M., Iftner T. Population-based prevalence, type- and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark. Int J Cancer 2008, 123(October (8)):1864-1870.
23. Styregruppen for DKLS. årsrapport DKLS 2010: Dansk Kvalitetsdatabase for Livmoderhalskræftscreening [Annual report 2010: Danish Quality Assurance database for cervical cancer screening]. URL: [last accessed: 21.11.11]. https://www.sundhed.dk/Fil.ashx%3Fid=15486%26ext=pdf%26navn=DKLS_aarsrapport_2010.pdf.
24. Bouvard V., Baan R., Straif K., Grossey Y., Secretan B., El Ghissassi F., et al. A review of human carcinogens-part B: biological agents. Lancet Oncol 2009, 10(April (4)):321-322.
25. Hilsenbeck S.G., Clark G.M. Practical p-value adjustment for optimally selected cutpoints. Stat Med 1996, 15(January (1)):103-112.
26. Danmark Statistik. Danmark Statistik - Statistikbanken [StatBank Denmark]. URL: [last accessed: 01.08.12. http://www.statistikbanken.dk/statbank5a/default.asp?w=1472.
27. Eklund C., Forslund O., Wallin K.L., Zhou T., Dillner J. The 2010 global proficiency study of human papillomavirus genotyping in vaccinology. J Clin Microbiol 2012, 50(July (7)):2289-2298.
28. Castle P.E., Schiffman M., Herrero R., Hildesheim A., Rodriguez A.C., Bratti M.C., et al. A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica. J Infect Dis 2005, 191(June (11)):1808-1816.
29. Castle P.E., Rodriguez A.C., Burk R.D., Herrero R., Wacholder S., Hildesheim A., et al. Long-term persistence of prevalently detected human papillomavirus infections in the absence of detectable cervical precancer and cancer. J Infect Dis 2011, 203(March (6)):814-822.
30. Kjaer S.K., Frederiksen K., Munk C., Iftner T. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence. J Natl Cancer Inst 2010, 102(October (19)):1478-1488.
31. Kulmala S.M., Shabalova I.P., Petrovitchev N., Sirjanen K.J., Gyllensten U.B., Johansson B.C., et al. Type-specific persistence of high-risk human papillomavirus infections in the New Independent States of the former Soviet Union Cohort Study. Cancer Epidemiol Biomarkers Prev 2007, 16(January (1)):17-22.
32. Plummer M., Schiffman M., Castle P.E., Maucort-Boulch D., Wheeler C.M. A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion. J Infect Dis 2007, 195(June (11)):1582-1589.